MTHFR 677C>T and 1298A>C polymorphisms and male infertility risk: a meta-analysis

Bingbing Wei1, Zhuoqun Xu, Jun Ruan

  • 1Department of Urology, Affiliated Wuxi People's Hospital of Nanjing Medical University, 299 Qingyang Road, Wuxi 214023, China. dr.wei@hotmail.com

Insights

The methylenetetrahydrofolate reductase (MTHFR) 677C>T polymorphism is linked to male infertility risk in Asian populations. This finding suggests MTHFR 677T may be a low-penetrant risk factor, particularly for Asian men.

Area of Science:

  • Genetics
  • Reproductive Medicine
  • Epidemiology

Background:

  • The methylenetetrahydrofolate reductase (MTHFR) gene, specifically the 677C>T and 1298A>C polymorphisms, has been investigated for its association with male infertility.
  • Previous epidemiological studies yielded conflicting results regarding this association.

Purpose of the Study:

  • To conduct a meta-analysis to precisely estimate the association between MTHFR 677C>T and 1298A>C polymorphisms and the risk of male infertility.
  • To clarify the conflicting findings from prior research.

Main Methods:

  • A comprehensive literature search identified relevant case-control studies.
  • Meta-analysis was performed using odds ratios (ORs) and 95% confidence intervals (CIs) to assess the association strength.
  • Stratified analysis by ethnicity was conducted.

Main Results:

  • Overall, neither the MTHFR 677C>T nor the 1298A>C polymorphisms showed a significant association with male infertility risk.
  • However, stratified analysis revealed a significant association between the MTHFR 677C>T polymorphism and increased male infertility risk in the Asian population.
  • Specific findings for the 677C>T polymorphism in Asians included ORs ranging from 1.34 to 1.57 across different genetic models.

Conclusions:

  • The MTHFR 677T allele may represent a low-penetrant risk factor for male infertility.
  • This association appears particularly relevant in the Asian population, despite potential for modest bias in the meta-analysis.

Related Concept Videos

Infertility in Males01:23

Infertility in Males

Male infertility affects millions of couples worldwide, arising from various factors that impact different stages of the reproductive process. An endocrine imbalance resulting from conditions like hypogonadism, Klinefelter syndrome, or pituitary disorders can disrupt hormone levels and reduce sperm production. Testicular defects, such as tumors, cryptorchidism, atrophic testes, abnormal sperm morphology, and low sperm count or motility, may arise due to genetic factors, structural...
Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu01:29

Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu

Genetic variations significantly influence drug response through pharmacokinetics, receptor interactions, and biologic milieu modifications. Pharmacokinetic alterations impact drug metabolism and clearance, affecting efficacy and toxicity. Variants in drug-metabolizing enzymes, such as CYP2C9 and CYP2C19, alter drug activation and elimination. For example, CYP2C9 loss-of-function variants require lower warfarin doses to prevent excessive bleeding, while CYP2C19 variants reduce clopidogrel...
Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase01:11

Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase

Genetic polymorphisms in drug targets have emerged as critical determinants of interindividual variability in drug response and toxicity. Pharmacogenomic investigations increasingly focus on identifying these variations to personalize and optimize therapeutic interventions. A drug target may be a receptor, enzyme, or signaling protein involved in pharmacologic responses or disease-related pathways. While early pharmacogenetic studies focused primarily on drug metabolism, current research...
Single Nucleotide Polymorphisms-SNPs01:05

Single Nucleotide Polymorphisms-SNPs

A single nucleotide polymorphism or SNP is a single nucleotide variation at a specific genomic position in a large population. It is the most prevalent type of sequence variation found in the human genome. Point mutations that occur in more than 1% of the population qualify as SNPs. These are present once every 1000 nucleotides on an average in the human genome. Replacement of a purine with another purine (A/G) or a pyrimidine with another pyrimidine (C/T) is known as a transition. In contrast,...
Pharmacogenomics: Identification of New Drug Targets01:29

Pharmacogenomics: Identification of New Drug Targets

Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...
Sex-linked Disorders01:43

Sex-linked Disorders

Like autosomes, sex chromosomes contain a variety of genes necessary for normal body function. When a mutation in one of these genes results in biological deficits, the disorder is considered sex-linked.